Early Versus Delayed Enteral Feeding for Achieving Full Feeding in Preterm Growth-Restricted Infants: A Randomized

F Ahmed1, S K Dey, M Shahidullah

  • 1Dr Farzana Ahmed, Associate Professor & Head, Department of Paediatrics, Marks Medical College Hospital, Dhaka, Bangladesh;

Insights

Early enteral feeding is beneficial for preterm infants with growth restriction. It helps them reach full feeding faster, regain birth weight quicker, and reduces hospital stays and complications like sepsis and feeding intolerance.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Perinatal Medicine

Background:

  • Optimal enteral nutrition is critical for growth-restricted preterm infants to prevent adverse physical and neurodevelopmental outcomes.
  • Antenatal chronic hypoxia increases susceptibility to feeding intolerance and necrotizing enterocolitis in these vulnerable infants.

Purpose of the Study:

  • To evaluate the impact of early versus delayed enteral feeding on growth-restricted preterm infants.
  • To assess the safety and efficacy of initiating enteral nutrition sooner in small for gestational age neonates.

Main Methods:

  • A randomized clinical trial involving 50 growth-restricted preterm infants (small for gestational age).
  • Infants were randomly assigned to either an early feeding group (n=25) or a late feeding group (n=25).
  • Clinical characteristics were balanced at trial entry.

Main Results:

  • The early feeding group reached full enteral feeds significantly faster (p=0.001; Hazard ratio 1.24).
  • Early feeding was associated with faster birth weight regain, reduced neonatal sepsis incidence, fewer feeding intolerances, and shorter hospital stays.
  • Higher weight gain was observed in the early feeding group by postnatal day 16.

Conclusions:

  • Early enteral feeding is safe and beneficial for growth-restricted preterm infants.
  • It effectively reduces the time to achieve full enteral feeding and promotes better weight gain.
  • This approach may improve overall outcomes for this high-risk neonatal population.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
571
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
893
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
519
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
71